ArticleOPEN ACCESS

Calreticulin arms NK cells against leukemia

OncoImmunology
DOI: 10.1080/2162402X.2019.1671763
14Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Calreticulin (CALR) exposed on the surface of cancer cells succumbing to therapy delivers robust phagocytic signals that support the activation of adaptive anticancer immune responses. Recent data from our group demonstrate that spontaneous CARL exposure on leukemic blasts also supports innate anticancer immunity by natural killer (NK) cells via an indirect mechanism relying on myeloid CD11c+CD14+ cells.

Author supplied keywords

Cite

CITATION STYLE

APA

Fucikova, J., Kline, J. P., Galluzzi, L., & Spisek, R. (2020, January 1). Calreticulin arms NK cells against leukemia. OncoImmunology. Taylor and Francis Inc. https://doi.org/10.1080/2162402X.2019.1671763

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free